Human thymopoiesis produces polyspecific CD8

TCR Thymopoiesis autoimmunity cross-reactivity heterologous immunity human immunology immunopathology inflammation mouse polyspecificity

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 03 2023
Historique:
received: 21 06 2022
accepted: 12 02 2023
medline: 3 4 2023
entrez: 30 3 2023
pubmed: 31 3 2023
Statut: epublish

Résumé

T-cell receptors (TCRs) are formed by stochastic gene rearrangements, theoretically generating >10

Identifiants

pubmed: 36995951
doi: 10.7554/eLife.81274
pii: 81274
pmc: PMC10063231
doi:
pii:

Substances chimiques

Antigens, Viral 0
Receptors, Antigen, T-Cell, alpha-beta 0
Receptors, Antigen, T-Cell 0
Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023, Quiniou et al.

Déclaration de conflit d'intérêts

VQ Valentin Quiniou is affiliated with Parean biotechnologies. The author has no financial interests to declare, PB, VM, PS, HV, ZZ, FM, NC, MB, BC, HV, MS, AS, BB, RM, EM, DK No competing interests declared, HP Hang-Phuong Pham is affiliated with ILTOO pharma and Parean biotechnologies. The author hasno financial interests to declare

Références

J Allergy Clin Immunol. 2017 Oct;140(4):1206-1210
pubmed: 28629751
Annu Rev Immunol. 2010;28:275-94
pubmed: 20307209
Cell Metab. 2018 Dec 4;28(6):946-960.e6
pubmed: 30078552
J Immunol. 2018 Apr 1;200(7):2263-2279
pubmed: 29483360
Nat Rev Immunol. 2019 Oct;19(10):643-657
pubmed: 31308521
Nat Rev Immunol. 2020 Aug;20(8):499-506
pubmed: 32493982
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13139-44
pubmed: 25157137
Nat Rev Immunol. 2002 Jun;2(6):417-26
pubmed: 12093008
PLoS One. 2015 Oct 28;10(10):e0141561
pubmed: 26509579
Semin Respir Crit Care Med. 2016 Aug;37(4):487-500
pubmed: 27486731
Annu Rev Immunol. 2019 Apr 26;37:547-570
pubmed: 30699000
Bioinformatics. 2019 Sep 1;35(17):2974-2981
pubmed: 30657870
Viral Immunol. 2008 Jun;21(2):99-113
pubmed: 18476772
Nature. 1988 Aug 4;334(6181):395-402
pubmed: 3043226
Annu Rev Immunol. 2015;33:169-200
pubmed: 25493333
J Biol Chem. 2012 Jan 6;287(2):1168-77
pubmed: 22102287
Nat Commun. 2021 Nov 5;12(1):6423
pubmed: 34741035
Immunity. 2021 Mar 9;54(3):586-602.e8
pubmed: 33691136
Elife. 2017 Jul 21;6:
pubmed: 28731407
Sci Adv. 2021 May 14;7(20):
pubmed: 33990328
Nat Immunol. 2016 Jan;17(1):87-94
pubmed: 26523866
Int J Epidemiol. 2003 Feb;32(1):106-16
pubmed: 12690020
Diabetes. 2020 Dec;69(12):2678-2690
pubmed: 32928873
Annu Rev Immunol. 2020 Apr 26;38:229-247
pubmed: 31928469
Nat Rev Immunol. 2014 Jun;14(6):377-91
pubmed: 24830344
Sci Transl Med. 2016 Mar 30;8(332):332ra46
pubmed: 27030598
Immunol Today. 1998 Sep;19(9):395-404
pubmed: 9745202
Cell. 2020 Nov 25;183(5):1264-1281.e20
pubmed: 33091337
Nature. 2017 Jul 6;547(7661):94-98
pubmed: 28636589
Nat Commun. 2018 Feb 8;9(1):561
pubmed: 29422654
BMJ. 2010 Nov 30;341:c6495
pubmed: 21118875
PLoS Comput Biol. 2019 Mar 4;15(3):e1006874
pubmed: 30830899
Cell. 1995 Mar 10;80(5):695-705
pubmed: 7534214
J Immunol. 2015 Jan 1;194(1):13-20
pubmed: 25527792
Diabetes. 2021 Dec;70(12):2879-2891
pubmed: 34561224
Nat Methods. 2015 May;12(5):380-1
pubmed: 25924071
Nucleic Acids Res. 2018 Jan 4;46(D1):D419-D427
pubmed: 28977646
Genome Res. 2021 Nov 23;:
pubmed: 34815307
Int J Epidemiol. 2005 Jun;34(3):540-7
pubmed: 15659474
J Hepatol. 2016 Apr;64(1 Suppl):S71-S83
pubmed: 27084039
Cell. 2014 May 22;157(5):1073-87
pubmed: 24855945
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Immunity. 2021 Aug 10;54(8):1825-1840.e7
pubmed: 34270940
Annu Rev Immunol. 2020 Apr 26;38:487-510
pubmed: 32017636
Bioinformatics. 2019 May 1;35(9):1461-1468
pubmed: 30247624
Annu Rev Immunol. 2016 May 20;34:479-510
pubmed: 26927205
Nat Biotechnol. 2021 Feb;39(2):236-245
pubmed: 32895550
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16161-6
pubmed: 22988065
Bioinformatics. 2017 Sep 15;33(18):2924-2929
pubmed: 28481982
Clin Exp Immunol. 2014 Jul;177(1):47-63
pubmed: 24673376
Sci Immunol. 2018 Feb 2;3(20):
pubmed: 29429978
Sci Transl Med. 2015 Apr 1;7(281):281ra43
pubmed: 25834109
Immunity. 2013 Feb 21;38(2):373-83
pubmed: 23395677
Cell. 2019 Aug 8;178(4):1016-1028.e13
pubmed: 31398327
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):274-8
pubmed: 10618408
Nature. 2017 Jul 6;547(7661):89-93
pubmed: 28636592
Nat Rev Immunol. 2012 Sep;12(9):669-77
pubmed: 22918468
Front Immunol. 2020 Apr 09;11:633
pubmed: 32328071
Immunity. 2014 Aug 21;41(2):181-90
pubmed: 25148022
Cell Rep. 2017 Apr 18;19(3):569-583
pubmed: 28423320
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Immunity. 2015 Jan 20;42(1):95-107
pubmed: 25601203
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2905-14
pubmed: 23858460
Nat Immunol. 2015 Nov;16(11):1114-23
pubmed: 26482978

Auteurs

Valentin Quiniou (V)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Pierre Barennes (P)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Vanessa Mhanna (V)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Paul Stys (P)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.

Helene Vantomme (H)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Zhicheng Zhou (Z)

Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.

Federica Martina (F)

AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Nicolas Coatnoan (N)

AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Michele Barbie (M)

AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Hang-Phuong Pham (HP)

ILTOO pharma, Statistical department, Paris, France.

Béatrice Clémenceau (B)

CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Henri Vie (H)

CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Mikhail Shugay (M)

Center of Life Sciences, Skoltech, Moscow, Russian Federation.

Adrien Six (A)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.

Barbara Brandao (B)

Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.

Roberto Mallone (R)

Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
Assistance Publique Hôpitaux de Paris, Service de Diabétologie et Immunologie Clinique, Cochin Hospital, Paris, France.

Encarnita Mariotti-Ferrandiz (E)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.

David Klatzmann (D)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH